Valuation (57%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -14.78 | 24.91 |
| PEG Ratio (TTM) | 4.39 | -0.41 |
| P/S Ratio (TTM) | 0.98 | 1.74 |
| P/B Ratio (TTM) | 1.56 | 2.21 |
| P/FCF Ratio (TTM) | -39.70 | 8.56 |
| Price to 5YR AVG Earnings Ratio | 11.11 | 11.01 |
| Price to 5YR AVG FCF Ratio | 10.87 | 10.53 |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -7.56% | 4.91% |
| ROE (TTM) | -9.61% | 16.22% |
| Net Profit Margin (TTM) | -6.74% | -26.40% |
| ROIC 5YR AVG | 26.90% | 21.45% |
Growth (40%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -136.93% | 38.40% | -14.29% |
| Revenue | -18.60% | 22.82% | 8.49% |
| Net Income | -135.01% | 38.37% | -14.42% |
| Cash Flow | -6.12% | 26.84% | 4.53% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.46 | 2.09 |
| Quick Ratio (TTM) | 0.41 | 0.89 |
| D/E Ratio (TTM) | 0.00 | 0.84 |
| Interest Coverage (TTM) | 22.35 | 1.30 |
| Piotroski F-Score | 5 | 7 |
| Altman Z-Score | 4.24 | 3.52 |
| LTL to 5YR AVG FCF | N/A | 4.95 |
| Shares Outstanding Growth 5YR AVG | -0.38% | -1.89% |